OKYO Pharma Announces Positive Safety Data Profile for the ongoing OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease (“DED”) cover

OKYO Pharma Announces Positive Safety Data Profile for the ongoing OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease ("DED") cover

Trending Tickers

WISH
$9.18
27.72%
WISH
$9.18
27.72%
WISH
$9.18
27.72%
Back to top button